JP2019526262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526262A5 JP2019526262A5 JP2019512264A JP2019512264A JP2019526262A5 JP 2019526262 A5 JP2019526262 A5 JP 2019526262A5 JP 2019512264 A JP2019512264 A JP 2019512264A JP 2019512264 A JP2019512264 A JP 2019512264A JP 2019526262 A5 JP2019526262 A5 JP 2019526262A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- recombinant
- lab
- pharmaceutical composition
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022010063A JP2022061035A (ja) | 2016-09-02 | 2022-01-26 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
| JP2024009123A JP2024047590A (ja) | 2016-09-02 | 2024-01-25 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662383079P | 2016-09-02 | 2016-09-02 | |
| US62/383,079 | 2016-09-02 | ||
| PCT/IB2017/055287 WO2018042390A1 (en) | 2016-09-02 | 2017-09-02 | Genetically modified bacteria stably expressing il-10 and insulin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022010063A Division JP2022061035A (ja) | 2016-09-02 | 2022-01-26 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019526262A JP2019526262A (ja) | 2019-09-19 |
| JP2019526262A5 true JP2019526262A5 (enExample) | 2020-10-15 |
| JP7016865B2 JP7016865B2 (ja) | 2022-03-03 |
Family
ID=60120085
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512264A Expired - Fee Related JP7016865B2 (ja) | 2016-09-02 | 2017-09-02 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
| JP2022010063A Pending JP2022061035A (ja) | 2016-09-02 | 2022-01-26 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
| JP2024009123A Pending JP2024047590A (ja) | 2016-09-02 | 2024-01-25 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022010063A Pending JP2022061035A (ja) | 2016-09-02 | 2022-01-26 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
| JP2024009123A Pending JP2024047590A (ja) | 2016-09-02 | 2024-01-25 | Ｉｌ－１０およびインスリンを安定的に発現する遺伝子改変された細菌 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10858663B2 (enExample) |
| EP (1) | EP3506932B1 (enExample) |
| JP (3) | JP7016865B2 (enExample) |
| CN (2) | CN118813511A (enExample) |
| AU (1) | AU2017319707B2 (enExample) |
| CA (1) | CA3035151A1 (enExample) |
| RU (1) | RU2768027C2 (enExample) |
| WO (1) | WO2018042390A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2768027C2 (ru) * | 2016-09-02 | 2022-03-23 | Интрексон Актобиотикс Н.В. | Генетически модифицированные бактерии, стабильно экспрессирующие ил-10 и инсулин |
| KR102348734B1 (ko) | 2016-09-13 | 2022-01-07 | 인트랙슨 액토바이오틱스 엔.브이. | 점막부착성 미생물 |
| WO2020132595A1 (en) * | 2018-12-21 | 2020-06-25 | The Regents Of The University Of California | Il-10-containing vaccines and uses thereof |
| IL322315A (en) | 2019-05-14 | 2025-09-01 | Provention Bio Inc | Methods and preparations for preventing type 1 diabetes |
| MX2022015872A (es) | 2020-06-11 | 2023-05-16 | Provention Bio Inc | Metodos y composiciones para prevenir diabetes tipo 1. |
| WO2024146463A1 (zh) * | 2023-01-03 | 2024-07-11 | 深圳先进技术研究院 | 分泌白介素-10的细菌 |
| CN116726158A (zh) * | 2023-04-24 | 2023-09-12 | 中国医学科学院医学生物学研究所 | 一种多表位1型糖尿病疫苗及其制备方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB227835A (en) | 1924-01-15 | 1925-04-09 | Harry Odell | Improvements in feeding mechanism for embossing and other printing presses |
| US4919918A (en) | 1988-03-14 | 1990-04-24 | Spectrum Consumer Products Co., Inc. | Non-alcoholic mouthwash |
| US5972685A (en) | 1988-07-21 | 1999-10-26 | Iowa State University Research Foundation, Inc. | Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration |
| GB9126306D0 (en) | 1991-12-11 | 1992-02-12 | Unilever Plc | Mouthwash compositions |
| GB2278358B (en) | 1992-02-27 | 1995-07-26 | Lynxvale Ltd | Heterologous gene expression in Lactococcus,and the expression products therefrom |
| US5223285A (en) | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
| US5700782A (en) | 1993-05-28 | 1997-12-23 | Abbott Laboratories | Enteral nutritional product |
| AU2149495A (en) | 1995-04-11 | 1996-10-30 | Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno | Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface |
| US5695746A (en) | 1995-07-28 | 1997-12-09 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Liquid dentifrice with mouthwash fresh taste |
| WO1997026855A1 (en) | 1996-01-24 | 1997-07-31 | Warner-Lambert Company | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems |
| GB9611364D0 (en) | 1996-05-31 | 1996-08-07 | Smithkline Beecham Plc | Composition |
| PT939613E (pt) | 1996-09-18 | 2003-07-31 | Erling Johansen | Solucao sobressaturada para lavagem bucal contendo ioes calcio e fosfato |
| US5869118A (en) | 1996-11-13 | 1999-02-09 | Abbott Laboratories | Gellan gum to improve physical stability of liquid nutritional products |
| US5897872A (en) | 1997-11-12 | 1999-04-27 | Picciano; Dante J. | Iodine-containing nasal moisturizing saline solution |
| US6171611B1 (en) | 1997-11-12 | 2001-01-09 | Dante J. Picciano | Iodine-containing nasal moisturizing saline and mouthwash solutions |
| EP1117386B1 (en) | 1998-09-28 | 2004-12-01 | Warner-Lambert Company | Enteric and colonic delivery using hpmc capsules |
| AU1071200A (en) | 1998-10-19 | 2000-05-08 | Biotech Australia Pty Limited | Systems for oral delivery |
| AU2002314040B2 (en) | 2001-05-03 | 2007-06-28 | Intrexon Actobiotics Nv | Self-containing lactococcus strain |
| US20040043003A1 (en) | 2002-01-31 | 2004-03-04 | Wei Chen | Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| US20040076590A1 (en) | 2002-07-08 | 2004-04-22 | Wilkins Joe S. | Antibacterial toothpaste and mouthwash formulations |
| AU2003303222A1 (en) * | 2002-12-19 | 2004-07-14 | Universiteit Gent | Mutant proteins showing increased secretion |
| ES2596855T3 (es) * | 2005-11-29 | 2017-01-12 | Intrexon Actobiotics Nv | Inducción de tolerancia mucosa a antígenos |
| RU2495129C2 (ru) | 2007-01-12 | 2013-10-10 | Актогеникс Н.В. | ПРОМОТОРЫ Lactococcus И ИХ ПРИМЕНЕНИЕ: |
| JP2010516269A (ja) | 2007-01-25 | 2010-05-20 | アクトジェニックス・エヌブイ | 抗原の粘膜送達による免疫疾患の治療 |
| CA2682327A1 (en) | 2007-03-28 | 2008-10-02 | Alimentary Health Limited | Probiotic bifidobacterium strains |
| JP5572972B2 (ja) * | 2009-03-16 | 2014-08-20 | Ｊｎｃ株式会社 | インスリン分泌促進剤などの薬物のスクリーニング方法 |
| JP5897459B2 (ja) | 2009-04-30 | 2016-03-30 | イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ | 乳酸菌のフリーズドライのための凍結保護剤 |
| RU2644346C2 (ru) | 2011-06-01 | 2018-02-08 | Интрексон Актобиотикс Н.В. | Система полицистронной экспрессии для бактерий |
| DK2758512T3 (en) * | 2011-09-23 | 2018-07-23 | Intrexon Actobiotics Nv | MODIFIED GRAM POSITIVE BACTERIES AND APPLICATIONS THEREOF |
| EP2758513B1 (en) * | 2011-09-23 | 2018-05-16 | Intrexon Actobiotics NV | Modified gram positive bacteria and uses thereof |
| RU2768027C2 (ru) * | 2016-09-02 | 2022-03-23 | Интрексон Актобиотикс Н.В. | Генетически модифицированные бактерии, стабильно экспрессирующие ил-10 и инсулин |
-
2017
- 2017-09-02 RU RU2019104948A patent/RU2768027C2/ru active
- 2017-09-02 JP JP2019512264A patent/JP7016865B2/ja not_active Expired - Fee Related
- 2017-09-02 CN CN202410943767.1A patent/CN118813511A/zh active Pending
- 2017-09-02 AU AU2017319707A patent/AU2017319707B2/en active Active
- 2017-09-02 CN CN201780054190.7A patent/CN109843320A/zh active Pending
- 2017-09-02 US US16/329,321 patent/US10858663B2/en active Active
- 2017-09-02 CA CA3035151A patent/CA3035151A1/en active Pending
- 2017-09-02 EP EP17784999.9A patent/EP3506932B1/en active Active
- 2017-09-02 WO PCT/IB2017/055287 patent/WO2018042390A1/en not_active Ceased
-
2020
- 2020-11-09 US US17/092,624 patent/US11549118B2/en active Active
-
2022
- 2022-01-26 JP JP2022010063A patent/JP2022061035A/ja active Pending
- 2022-11-29 US US18/059,689 patent/US12359210B2/en active Active
-
2024
- 2024-01-25 JP JP2024009123A patent/JP2024047590A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526262A5 (enExample) | ||
| Ma et al. | Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice | |
| Heiseke et al. | CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell–mediated protection from colitis | |
| Rutella et al. | Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease | |
| US20220023358A1 (en) | Combination therapies of microorganisms and immune modulators for use in treating cancer | |
| JP2019505524A (ja) | １型糖尿病を処置するための組成物および方法 | |
| US20230348918A1 (en) | Genetically Modified Bacteria Stably Expressing IL-10 and Insulin | |
| EP2839291B1 (en) | Multivalent breast cancer vaccine | |
| Huss et al. | TGF‐β signaling via Smad4 drives IL‐10 production in effector Th1 cells and reduces T‐cell trafficking in EAE | |
| KR101291960B1 (ko) | 장내세균에 의한 생물학적 활성제의 제어된 생산 및 전달 | |
| US20080026986A1 (en) | Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling | |
| TW201833323A (zh) | 重組李斯特菌屬疫苗菌株及在癌症免疫治療中使用該菌株之方法 | |
| KR20220092523A (ko) | 변이체 인터루킨-2 (vIL-2) 폴리펩타이드를 코딩하는 종양용해성 바이러스 벡터 | |
| Salio | Unconventional MAIT cell responses to bacterial infections | |
| Roider et al. | Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer | |
| CN113056479A (zh) | 腺病毒疫苗媒介物中的cd40和cd40l结合物 | |
| WO2022086988A1 (en) | Multi-functional and multi-valent interleukin-tgf-beta receptor fusion polypeptides | |
| AU2021367306A9 (en) | Multi-functional and multi-valent interleukin-tgf-beta receptor fusion polypeptides | |
| CN114761028A (zh) | 乳糜泻的治疗 | |
| Kong et al. | Expression of fusion IL2-B7. 1 (IgV+ C) and effects on T lymphocytes | |
| WO2024216073A1 (en) | Engineered microbes comprising tumor neoantigen vectors for cancer immunotherapy | |
| CN120476198A (zh) | 分泌白介素-10的细菌 | |
| Memory | Differential Requirements for OX40 Signals |